Probiotic potential of commercial available probiotic preparations in prevention of enteric bacterial infections: An in-vitro study

International Journal of Pharmaceutical Sciences Review and Research

Volumn 9, Issue 2, 2011, Pages 7-11

  Bhutada, S A ^a   Dahikar, S B ^a   Tambekar, D H ^a  

^a SANT GADGE BABA AMRAVATI UNIVERSITY   (India)

Author keywords

Antibacterial activity; Enteric bacterial infection; Probiotics preparations

Indexed keywords

AMPICILLIN; BACTERIOCIN; BILE SALT; CEFALOTIN; COTRIMOXAZOLE; GASTROLINE; GENTAMICIN; LACTOBACIL PLUS; NALIDIXIC ACID; NITROFURANTOIN; NORFLOXACIN; P BIOTICS KID; PRE PRO KID; PROBIOTIC AGENT; SPORLAC; TETRACYCLINE; UNCLASSIFIED DRUG;

ACID TOLERANCE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; COMMERCIAL PHENOMENA; CONTROLLED STUDY; DISK DIFFUSION; DRUG EFFECT; DRUG POTENCY; DRUG SCREENING; ENTEROBACTER AEROGENES; ESCHERICHIA COLI; IN VITRO STUDY; INFECTION CONTROL; INFECTION PREVENTION; INTESTINE INFECTION; NONHUMAN; PROTEUS VULGARIS; SALMONELLA TYPHI; SHIGELLA FLEXNERI; STOMACH PH;

EID: 80052657334     PISSN: None     EISSN: 0976044X     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Alvarez-Olmos MI, Oberhelman RA, Probiotic agents and infectious diseases: a modern perspective on a traditional therapy. Clin Infectious Diseases, 2001, 32 (11):1567-1576.
2. Culligan EP, Hill C and Sleator RD, Probiotics and gastrointestinal disease: successes, problems, and future prospects. Gut pathogens, 2009, 1(19):1-12.
3. World Health Organization, http://www.who.int/info/healthinfo/globalburdendisease/GBDreportpart2,pdf, 2004.
4. Ballal M and Shivananda PG, Rotavirus and enteric pathogens in infantile diarrhoea in Manipal, South India. Indian J Pediatr, 2002,69:393-396.
5. Fuller R, Probiotics in human medicine, 1991, Gut 32: 439-442.
6. Ahmed FE, Genetically modified probiotics in foods. Trends Biotechnol. 2003, 21, 491-497.
7. Chapoy P, Treatment of acute infantile diarrhoea: controlled trial of Saccharomyces boulardii. Ann Pediatr (Paris), 1985, 32:561.
8. Saggioro A, Probiotics in the treatment of irritable bowel syndrome. J Clin Gastroenterol, 2004, 38(6):S104-106.
9. Vamanu A, Vamanu E, Drugulescu M, Popa O and Camceanu G, Identificaion of a lactic acid bacterium starin used for obtaining a colon based probiotic product. Turk J boil, 2006, 30: 75-80.
10. Voravuthikunchai SP, Bilasoi S and Supamala, Antimicrobial susceptibility colon antagonistic activity against pathogenic bacteria by human viginal Lactobacilli. Anaerobe 2006, 12: 221-226.
11. Kirby MM, Baur AW, Sherris JC, Tuurck M, Antibiotic susceptibility testing by a standardized single disk method. Am J Clinical Pathol, 1966,45:493-496.
12. Halami PM, Chandrashekar A and Joseph R, Characterization of bacteriocinogenic strains of lactic acid bacteria in fowl and fish intestines and mushroom. Food Biotechnol, 1999, 13(2):121-136.
13. Tagg, JR and McGiven, Assay system for bacteriocins. Appl Microbiol. 1971, 21:943.
14. Lade HS, Chitanand MP, Kadam TA, Gyanath G, Antibiotic resistance of bacteriocin producing Lactobacillus species isolated from curd and vegetables waste. The Bioscan Int Quarterly J Life Sci, 2007, 2(3):185-188.
15. Ogunbanwo ST, Sanni AI, and Onilude AA, Characterization of bacteriocin produced by Lactobacillus plantarum F1 and Lactobacillus brevis OG1. Afri J Biotechnol, 2003,2(8):219-227.
16. Lee YK and Salminen S, The coming of age of probiotics. Trends Food Sci Technol, 1995, 6:241-245.
17. Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, O'Halloran S, Feeney M, Flynn S, Fitzgerald G, Daly C, Kiely BC, O'Sullivan G, Shanahan F, and Collins JK, In vitro selection criteria for probiotic bacteria of human origin: Correlation with in vivo findings, Am J Clin Nutr, 2001, 73:386-392.
18. Havenaar R, Ten Brink B, Huis in't Veld JHJ, Selection of strains for Probiotic use. In: Probiotics.The Scientific Basis, R. Fuller (Ed) Chapman and Hall, London, 1992, 209:221.
19. Tambekar DH and Bhutada SA, Studies on antimicrobial activity and characteristics of bacteriocins produced by Lactobacillus strains isolated from milk of domestic animals. The Internet J Microbiol, 2010, 8:1-6
20. Tambekar DH, Bhutada SA, Choudhary SD and Khond MD, Assessment of potential probiotic bacteria isolated from milk of domestic animals. J Appl Biosci, 2009, 15: 815-819.
21. Bezkorvainy A, Probiotics: Determinants of survival and growth in the gut. Am J Clin. Nutr 2001,73:399-405.
22. EI-Naggar MYM, Comparative study of probiotic cultures to control the growth of E. coli O157:H7 and Salmonella typhimurium. Biotechnol, 2004, 3:173-180.
23. Ouwehand AC, Salvadori BN, Fonden R, Mogensen G, Salminen S and Sellers R, Health effects of probiotics and cultrure-containing dairy products in humans. IDF, 2003, 380:4-19.